key: cord-0934738-6ow5wb4s
authors: Nguyen, Lee S.; Helias, Marion; Raia, Lisa; Nicolas, Estelle; Jaubert, Paul; Benghanem, Sarah; Ait Hamou, Zakaria; Dupland, Pierre; Charpentier, Julien; Pène, Frédéric; Cariou, Alain; Mira, Jean-Paul; Chiche, Jean-Daniel; Jozwiak, Mathieu
title: Impact of COVID-19 on the association between pulse oximetry and arterial oxygenation in patients with acute respiratory distress syndrome
date: 2022-01-27
journal: Sci Rep
DOI: 10.1038/s41598-021-02634-z
sha: ebc8eb62f30665befe90f1308338edf44b3688a2
doc_id: 934738
cord_uid: 6ow5wb4s

Managing patients with acute respiratory distress syndrome (ARDS) requires frequent changes in mechanical ventilator respiratory settings to optimize arterial oxygenation assessed by arterial oxygen partial pressure (PaO(2)) and saturation (SaO(2)). Pulse oxymetry (SpO(2)) has been suggested as a non-invasive surrogate for arterial oxygenation however its accuracy in COVID-19 patients is unknown. In this study, we aimed to investigate the influence of COVID-19 status on the association between SpO(2) and arterial oxygenation. We prospectively included patients with ARDS and compared COVID-19 to non-COVID-19 patients, regarding SpO(2) and concomitant arterial oxygenation (SaO(2) and PaO(2)) measurements, and their association. Bias was defined as mean difference between SpO(2) and SaO(2) measurements. Occult hypoxemia was defined as a SpO(2) ≥ 92% while concomitant SaO(2) < 88%. Multiple linear regression models were built to account for confounders. We also assessed concordance between positive end-expiratory pressure (PEEP) trial-induced changes in SpO(2) and in arterial oxygenation. We included 55 patients, among them 26 (47%) with COVID-19. Overall, SpO(2) and SaO(2) measurements were correlated (r = 0.70; p < 0.0001), however less so in COVID-19 than in non-COVID-19 patients (r = 0.55, p < 0.0001 vs. r = 0.84, p < 0.0001, p = 0.002 for intergroup comparison). Bias was + 1.1%, greater in COVID-19 than in non-COVID-19 patients (2.0 vs. 0.3%; p = 0.02). In multivariate analysis, bias was associated with COVID-19 status (unstandardized β = 1.77, 95%CI = 0.38–3.15, p = 0.01), ethnic group and ARDS severity. Occult hypoxemia occurred in 5.5% of measurements (7.7% in COVID-19 patients vs. 3.4% in non-COVID-19 patients, p = 0.42). Concordance rate between PEEP trial-induced changes in SpO(2) and SaO(2) was 84%, however less so in COVID-19 than in non-COVID-19 patients (69% vs. 97%, respectively). Similar results were observed for PaO(2) regarding correlations, bias, and concordance with SpO(2) changes. In patients with ARDS, SpO(2) was associated with arterial oxygenation, but COVID-19 status significantly altered this association.

Patients and data collection. We included all consecutive patients admitted in our ICU department for acute respiratory failure and presented ARDS criteria, according to Berlin definition 26 at the initial phase of ventilatory management (within one hour after intubation). Exclusion criteria were those related to known causes of low-reliability of SpO 2 measurements: (i) low-quality SpO 2 signal assessed on the SpO 2 curve aspect and (ii), patients with nail varnish, methaemoglobinemia or carbon monoxide poisoning 4 and (iii), patients with marked movements leading to SpO 2 signal artefacts 27 .

ARDS severity was categorized as mild for PaO 2 /FiO 2 ratio between 200 and 300 mmHg, moderate between 100 and 200 mmHg, and severe, under 100 mmHg 26 .

Data were prospectively collected using a clinical software allowing data management and extraction, Centricity Critical Care (General Electric Healthcare, Massachusetts, United States of America). SpO 2 and SaO 2 measurements. SpO 2 was continuously measured using a finger or ear probe of a last generation pulse oximeter (Masimoset®, Masimo Corporation, Irvine, CA, USA). The location of SpO 2 probe was left at the discretion of nurses to obtain the best possible SpO 2 signal. The pulse oximeter was connected to patients' monitor (GE Healthcare, Chicago, Il, USA) and SpO 2 signal maximized on the monitor screen. SpO 2 measurement was recorded at the time the arterial blood gas was performed by the patient's nurse.

A blood sample was obtained from radial or femoral arterial catheter, not necessarily located on the same side as SpO 2 probe. SaO 2 was measured with the ICU blood gas analyser (ABL800, Radiometer®, Copenhagen, Denmark) and thus obtained within five minutes of blood sampling.

Occult hypoxemia was defined as SaO 2 < 88%, while concomitant SpO 2 measure was ≥ 92% 21 .

Ventilatory settings and respiratory measurements. All patients were placed in 45-degree semirecumbent position and mechanically ventilated (CARESCAPE R860, GE Healthcare, Chicago, Il, USA) in pressure regulated volume control mode. Tidal volume was set at 6 mL/kg of predicted body weight. Respiratory rate and inspiratory/expiratory times ratio were adjusted to prevent hypercapnia (pH goal: 7.30-7.45) and to avoid dynamic hyperinflation, without exceeding a respiratory rate of 35 breaths/min 12, 28 . The fraction of inspired oxygen (FiO 2 ) was adjusted to obtain a SpO 2 ≥ 90% 29 . An airway humidification system was used in all patients. The plateau pressure was calculated during a 5-s inspiratory hold and total PEEP during a 5-s expiratory hold. The driving pressure was calculated as the difference between plateau pressure and total PEEP. The static respiratory system compliance was calculated as tidal volume/(plateau pressure-total PEEP).

Since only patients with moderate to severe ARDS with a high potential for lung recruitment benefit from high PEEP strategies and since the amount of potentially recruitable lung vary widely in the population 30 , we systematically performed a PEEP trial in all patients with ARDS to individualize at best the initial PEEP level 29 . According to local protocols, PEEP level was initially set at 5 cmH 2 O 31 and a first set of measurements, including SpO 2 , SaO 2 and PaO 2 was performed. Then, PEEP was increased to 15 cmH2O and a second set of measurements was performed. All measurements were recorded after a 10-min period of stabilization 32 and two couples of simultaneous SpO 2 and SaO 2 measurements were obtained per patient. Other ventilatory settings were unchanged during the study period.

COVID-19 diagnosis. All patients were confirmed with SARS-Cov-2 using routine RT-PCR methodology, with two sets: either Allplex® 2019-nCoV assay (Seegene, Seoul, South Korea) with Microlab NIMBUS® extractor (Hamilton Bonaduz AG, Rapperswil-Jona, Switzerland) and CFX96® thermocycler (Bio-Rad laboratories, Hercules, California, United States of America); or RealStar® SARS-CoV-2 RT-PCR Kit 1.0 assay (Altona Diagnostics, Hamburg, Germany) with QIAsymphony SP® extractor (QIAGEN, Hilden, Germany) and QuantStudio® thermocycler (Thermo Fisher Scientific, Waltham, Massachusetts, United States of America). RT-PCR was performed on nasopharyngeal swabs or on distal bronchial samples. We used four different methods to assess the association between SaO 2 and SpO 2 : correlations, agreement, multivariable regression models and concordance. Specifically, correlations were performed using Pearson or Spearman's correlation coefficients, according to data distribution. Agreement between SpO 2 and SaO 2 measurements was assessed with Bland-Altman analysis 33 and intraclass correlation coefficients (ICC), with ICC value > 0.7 and > 0.9 indicating satisfactory and excellent agreement respectively 34 . Accuracy of SpO 2 measurement was estimated by the bias, calculated as the mean difference between SpO 2 and SaO 2 measurements. Precision of SpO 2 measurement was estimated by the standard deviation of the bias and the 95% limits of agreement 33 . The concordance between relative changes in SpO 2 and SaO 2 was assessed (i) with a four-quadrant plot analysis 35 , (ii) the clinical concordance method 36 and (iii) the inter-rater agreement kappa coefficient (κ), with κ-value < 0.20 and > 0.80 indicating poor and good strength of agreement respectively 37 .

Multiple linear regressions were performed to identify variables associated with the dependent variable SpO 2 . Separate models were built depending on the selected variable (SaO 2 or PaO 2 ) in regard to SpO 2 . Moreover, multivariable models accounted for confounding variables (in regard to SpO 2 ), and their interactions: SaO 2 or PaO 2 , COVID-19 status, ethnic group, PEEP level, FiO 2 setting, temperature, SpO 2 probe and arterial catheter side (ipsilateral or contralateral), ARDS severity (as defined above, with mild category used as reference) and norepinephrine administration (defined as a categorical binary variable) [14] [15] [16] [17] [18] [19] [20] [21] .

Assuming a correlation coefficient of 0.69 between SpO 2 and SaO 2 38 and an ICC > 0.9 with a 95% confidence interval (CI) (0.84-0.96), we planned to include at least 50 patients with at least 25 COVID-19 patients. A p value < 0.05 was considered statistically significant. Statistical analyses were performed using MedCalc 11.6.0 software (MedCalc®, Mariakerke, Belgium), and SPSS version 25.0 (IBM®, Armonk, USA).

Personnes Ile-de-France X (IDCRB2018-A00050-55, protocol 59-2018) and by the Ethics Committee of the Société de Réanimation de Langue Française (CE SRLF 20-72) 25 , which waived the need for informed consent, following national regulation on standard-of-care data collection. Indeed, this study was performed on data collected in the course of a prospective data collection, without any additional blood sample, as compared to standard of care. As such, only refusal to participate was systematically sought.

Patient characteristics. Among 55 included patients: 33(60%) were men, 17(31%) were black and no patient had sickle-cell anaemia history. The ICU mortality rate was 38%. All patients had pulmonary ARDS and 26(47%) had an ARDS related to COVID-19. COVID-19 patients were more frequently black, tended to have more diabetes mellitus and had a lower SAPS-3 than non-COVID-19 patients ( Table 1 ). The other characteristics of patients are shown in Tables 1 and 2. A SpO 2 finger probe was used in all patients but three and a radial arterial catheter was used in 39(71%) patients. SpO 2 probe and arterial catheter were located on the same side in 30(55%) patients (Table 1) . SpO 2 values ranged from 83 to 100% and SaO 2 values from 80 to 100%. Carboxyhaemoglobin and methaemoglobin rates were < 2% in all patients.

Association between SpO 2 , SaO 2 and PaO 2 . In the whole population, SpO 2 and SaO 2 measurements were significantly correlated (r = 0.70, p < 0.0001). Correlation between SpO 2 and SaO 2 was lower in COVID-19 than in non-COVID-19 patients (r = 0.55, p < 0.0001 vs. r = 0.84, p < 0.0001, p = 0.002 for intergroup comparison) (Fig. 1A) . After adjusting for confounding covariables, variables independently associated with SpO 2 were: SaO 2 (unstandardized β = 0.46, 95%CI = 0.35-0.57, p < 0.0001), COVID-19 status (unstandardized β = 1.96, 95%CI = 1.03-2.88 l, p < 0.0001) and PEEP level (unstandardized β = 0.11, 95%CI = 0.01-0.21, p = 0.03).

For sensitivity, correlation between SpO 2 and PaO 2 was also assessed and found significant (r = 0.62, p < 0.0001). Similarly, correlation between SpO 2 and PaO 2 was lower in COVID-19 than in non-COVID-19 patients (r = 0.47, p= 0.001 vs. r = 0.75, p < 0.0001, p = 0.002 for intergroup comparison) (Fig. 1B) . After adjusting for confounding covariables, variables independently associated with SpO 2 were: PaO 2 (unstandardized β = 0.03, 95%CI = 0.02-0.05, p < 0.0001), COVID-19 status (unstandardized β = 2.04, 95%CI = 0.99-3.08, p < 0.0001) and PEEP level (unstandardized β = 0.17, 95%CI = 0.06-0.28, p = 0.002).

In the whole population, the bias between SpO 2 and SaO 2 measurements was 1.1%, the precision was 3.4% and the limits of agreement ranged from -5.6 to + 7.9% ( Fig. 2A) . Bias and SaO 2 measurements were significantly correlated (r = -− 0.56, p < 0.0001). The bias was higher (2.0 vs. 0.3%; p = 0.02) and the precision lower 

In the whole population, PEEP increase from 5 to 15 cmH2O significantly increased SpO 2 , SaO 2 and PaO 2 by 3 ± 4%, 4 ± 5% and 43 ± 57% respectively, (Table S1 ). SpO 2 changes were significantly correlated to that of SaO 2 (r = 0.65, p < 0.0001) and PaO 2 (r = 0.47, p < 0.001). The concordance rate between PEEP trial-induced changes in SpO 2 and SaO 2 was 84% (Fig. 3A ) and the κ-coefficient was 0.60. The concordance rate between PEEP trial-induced changes in SpO 2 and PaO 2 was 85% and the κ-coefficient was 0.55 ( Figure S1 ).

Concordance rate between PEEP trial-induced changes in SpO 2 and SaO 2 was lower in COVID-19 than in non-COVID-19 patients (69 vs. 97%), as was the κ-coefficient (0.35 vs. 1.00) (Fig. 3B) . Similar results were found for PaO 2 (73 vs. 97% for concordance rate and 0.28 vs. 1.00 for the κ-coefficient) ( Figure S1 ).

A reliable SpO 2 measurement would be interesting in patients with ARDS, given the medico-economic impact of the decrease in arterial blood gas analysis overuse 10 . In this cohort of patients with ARDS monitored with last generation pulse oximeter, we found that (i) SpO 2 was overall well-correlated with arterial oxygenation (SaO 2 and PaO 2 ) and that SpO 2 slightly overestimated SaO 2 , (ii) COVID-19 status significantly impacted the association between SpO 2 and arterial oxygenation (SaO 2 and PaO 2 ) and (iii), changes in SpO 2 could not reliably track changes in arterial oxygenation (SaO 2 and PaO 2 ) during PEEP trial in COVID-19 patients.

The accuracy of SpO 2 measurement in ICU is still debated because of several confounding factors [14] [15] [16] [17] [18] [19] [20] 39, 40 with an unconstant and unpredictable bias between SpO 2 and SaO 2 measurements 14, 15, [18] [19] [20] 39, 41 . Overall, we found that SpO 2 and arterial oxygenation (SaO 2 and PaO 2 ) were well-correlated and that SpO 2 only slightly overestimated SaO 2 but with wide limits of agreement, suggesting the lack of precision of SpO 2 measurement. Our results are comparable to those from previous ICU studies, which found similar correlation 38 and a bias ranging from 0.2 to 3% 14, 15, 38, 40, 42 with a mean bias of 1.5% 43 but wide limits of agreement 14, 15, 38, 40, 42 , highlighting the lack of improvement in the last generation pulse oximeter reliability. We also confirmed that that SpO 2 measurement was still less reliable in black 21 and in most hypoxemic [14] [15] [16] [17] [18] patients. It has been very recently shown that black patients had nearly three times the frequency of occult hypoxemia that was not detected by SpO 2 measurement as Caucasian patients 21 . Conversely to previous studies 14, 39 , we also found that changes in SpO 2 could track changes in arterial oxygenation (SaO 2 and PaO 2 ) during PEEP trial with a moderate to good strength of agreement. To our knowledge, this is one of the first studies analyzing not only the magnitude (correlation) but also the direction www.nature.com/scientificreports/ (concordance rate and κ-coefficient) of SpO 2 and SaO 2 changes. The discrepancy of our results to those of previous studies may be explained by the fact that rather than considering multiple therapeutic manoeuvres 15, 40 , we only considered a PEEP trial to ensure that the possible lack of agreement between changes in SpO 2 and SaO 2 could not be attributed to the multiple therapeutic manoeuvres used. We found that COVID-19 significantly impacted the association between SpO 2 and arterial oxygenation (SaO 2 and PaO 2 ). First, SpO 2 measurement was less reliable, as illustrated be weaker correlation, higher bias, wider limits of agreement, lower precision and lower ICC with an ICC < 0.7. Second, changes in SpO 2 could not reliably track changes in arterial oxygenation (SaO 2 and PaO 2 ) during PEEP trial, with a concordance rate of 69% and a κ-coefficient of 0.35 for changes in SaO 2 and a concordance rate of 73% and a κ-coefficient of 0.28 for changes in PaO 2 in COVID-19 patients, but a concordance rate of 97% and a κ-coefficient of 1.00 both for SaO 2 and PaO 2 in non-COVID-19 patients. To our knowledge, this is the first study investigating the reliability of SpO 2 measurement in COVID-19 patients, despite it has been suggested to use SpO 2 monitoring in these patients to detect "silent hypoxemia" 44, 45 . Importantly, the impact of COVID-19 on the association between SpO 2 and arterial oxygenation cannot be explained solely by the fact that COVID-19 patients were predominantly black 22 . Moreover, the proportion of occult hypoxemia that we observed was that expected of our population, although Table 2 . Respiratory, haemodynamic and oxygenation effects of the PEEP trial according to patients' COVID-19 status. Variables are expressed as median [interquartile] . No missing values, except otherwise specified between {}. NA: non-available. PaO 2 partial arterial pressure of oxygen, PaCO 2 partial arterial pressure of carbon dioxide; PBW: predicted body weight, PEEP positive end-expiratory pressure, SaO 2 arterial oxygen saturation, SpO 2 pulse oximetry. *p < 0.05 PEEP + 15 vs. PEEP + 5 cmH2O. £ p < 0.05 non-COVID-19 versus COVID-19 patients. Formulas: driving pressure = plateau pressure-total PEEP; respiratory system compliance = tidal volume/(plateau pressure-total PEEP). www.nature.com/scientificreports/ no thorough analysis could be performed on this criterion due to its low prevalence. Indeed, although lack of power may have been involved, interaction analyses did not yield significant association between COVID-19 status, ethnic group and SpO 2 . With caution, this may suggest that COVID-19 per se may alter the accuracy of SpO 2 measurement and the agreement between SpO 2 and arterial oxygenation. This could be explained by the fact that COVID-19 patients may experience systemic microvascular alterations that appear to be common and linked to coagulopathy 24 and/or endothelial dysfunction and endotheliitis 46 . Indeed, it has been shown that SARS-CoV-2 infection may facilitate the induction of endotheliitis with viral elements within endothelial cells and accumulation of inflammatory cells leading to apoptosis found in in several organs 46 . Further studies are needed to address the potential impact of COVID-19 on SpO 2 measurement. The clinical implications of our results are two-fold. In non COVID-19 patients, our results suggest that SpO 2 measurements with latest generation pulse oximeter may be sufficient to monitor and track changes in arterial oxygenation in the most critically-ill patients. Thus, arterial blood gazes may not be necessarily mandatory after every ventilatory setting modification during the weaning process in patients with ARDS. Moreover, our results confirm those published by Martínez-Balzano who showed that there was an overuse of arterial blood gazes in critically ill patients and that their number could be reduced without negatively impacting patient care but with clear medico-economic impact 10 . Meanwhile, in COVID-19 patients, SpO 2 measurement may not be as reliable, and iterative arterial blood gazes' analyses to measure SaO 2 may still be mandatory.

Our study has some limitations. First, we assessed only one type of last generation pulse oximeter. Second, we only considered the same two PEEP levels in all patients and we cannot exclude that considering other PEEP levels might influence the association between SpO 2 and SaO 2 as well as the concordance between PEEP trialinduced SpO 2 and SaO 2 changes. Third, we did not study, as previous studies 18, 40, 41 , the influence of carboxyhaemoglobin and methaemoglobin on the accuracy of SpO 2 measurement. Indeed, pulse oximeters cannot differentiate between these two forms of haemoglobin and oxyhaemoglobin, leading to SaO 2 overestimation in patients with high carboxyhaemoglobin and/or methaemoglobin rates 47, 48 . Yet, we systematically excluded patients with methaemoglobinemia or carbon monoxide poisoning (all had carboxyhaemoglobin and methaemoglobin rates < 2%). Interestingly, Kerget and colleagues very recently showed that endogenous carboxyhaemoglobin may be an easily accessible biomarker of clinical course and prognosis in COVID-19 patients 49 . Fourth, we did not perform multiple arterial blood gas analyses, which may have allowed the estimation of the metrological precision feature of the pulse oximeter device. Indeed, random error variability of replicate measurements, defined as www.nature.com/scientificreports/ precision, usually requires to perform multiple measurements for a given timepoint 50 . In our study, we did not deem ethical to sample arterial blood gases several times for each datapoint. We pragmatically assumed that precision remained constant and random error measurements were reproducible, following the device specifications 51 .

In patients with ARDS, SpO 2 was associated with arterial oxygenation (SaO 2 and PaO 2 ) and could track changes in arterial oxygenation with good reliability. Nevertheless, COVID-19 status significantly impacted the association between SpO 2 and arterial oxygenation. 

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. 

Clinical characteristics of coronavirus disease 2019 in China

Clinical course and outcomes of 344 intensive care patients with COVID-19

Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the lombardy region

Pulse oximetry

Randomized evaluation of pulse oximetry in 20,802 patients: II. Perioperative events and postoperative complications

The impact of continuous pulse oximetry monitoring on intensive care unit admissions from a postsurgical care floor

Effect of pulse oximetry on clinical practice in the intensive care unit

Use of a pulse oximeter in an adult emergency department: impact on the number of arterial blood gas analyses ordered

More reliable oximetry reduces the frequency of arterial blood gas analyses and hastens oxygen weaning after cardiac surgery: a prospective, randomized trial of the clinical impact of a new technology

An educational intervention optimizes the use of arterial blood gas determinations across ICUs from different specialties: a quality-improvement study

Comparison of the SpO 2 /FIO 2 ratio and the PaO 2 /FIO 2 ratio in patients with acute lung injury or ARDS

Effect of titrating positive end-expiratory pressure (PEEP) with an esophageal pressure-guided strategy vs an empirical high PEEP-Fio 2 strategy on death and days free from mechanical ventilation among patients with acute respiratory distress syndrome: a randomized clinical trial

Liberal or conservative oxygen therapy for acute respiratory distress syndrome

The accuracy of pulse oximetry in emergency department patients with severe sepsis and septic shock: a retrospective cohort study

Accuracy of pulse oximetry in the intensive care unit

Accuracy of response of six pulse oximeters to profound hypoxia

Errors in 14 pulse oximeters during profound hypoxia

Reliability of pulse oximetry in titrating supplemental oxygen therapy in ventilator-dependent patients

Accuracy of pulse oximetry in patients with low systemic vascular resistance

The accuracy of the Biox 3700 pulse oximeter in patients receiving vasoactive therapy

Racial bias in pulse oximetry measurement

Hospitalization and mortality among black patients and white patients with Covid-19

Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study

Microvascular alterations in patients with SARS-COV-2 severe pneumonia

Use of venovenous extracorporeal membrane oxygenation in critically-Ill patients with COVID-19

Acute respiratory distress syndrome: the Berlin Definition

Four types of pulse oximeters accurately detect hypoxia during low perfusion and motion

Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial

Formal guidelines: management of acute respiratory distress syndrome

Lung recruitment in patients with the acute respiratory distress syndrome

Lung recruitability is better estimated according to the Berlin definition of acute respiratory distress syndrome at standard 5 cm H2O rather than higher positive end-expiratory pressure: a retrospective cohort study

Response time of pulse oximeters assessed using acute decompression

Statistical methods for assessing agreement between two methods of clinical measurement

Intraclass correlations: uses in assessing rater reliability

A critical review of the ability of continuous cardiac output monitors to measure trends in cardiac output

Methodology of method comparison studies evaluating the validity of cardiac output monitors: a stepwise approach and checklist

Kappa coefficients in medical research

Facing SpO 2 and SaO 2 discrepancies in ICU patients: is the perfusion index helpful

Transesophageal versus surface pulse oximetry in intensive care unit patients

Do changes in pulse oximeter oxygen saturation predict equivalent changes in arterial oxygen saturation

Evidence for the need of bedside accuracy of pulse oximetry in an intensive care unit

Bias and precision of pulse oximeters and arterial oximeters

Comparative evaluation of accuracy of pulse oximeters and factors affecting their performance in a tertiary intensive care unit

Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting?

Pulse oximetry for monitoring patients with COVID-19 at home. Potential pitfalls and practical guidance

Endothelial cell infection and endotheliitis in COVID-19

Pulse oximetry in methemoglobinemia

Confirmation of the pulse oximetry gap in carbon monoxide poisoning

Is endogenous carboxyhaemoglobin level a useful biomarker of clinical course and prognosis in COVID-19 patients?

Metrology part 1: definition of quality criteria

Accuracy and precision of four common peripheral temperature measurement methods in intensive care patients

recruited patients and collected data

The authors declare no competing interests.

Supplementary Information The online version contains supplementary material available at https:// doi. org/ 10. 1038/ s41598-021-02634-z.Correspondence and requests for materials should be addressed to M.J.Reprints and permissions information is available at www.nature.com/reprints.Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.